COVID-19 Impact on PerkinElmer Inc.’s Revenue and Operations (Medical Devices)
Powered by
All the vital news, analysis, and commentary curated by our industry experts.
PerkinElmer Inc. (PerkinElmer), is a leading manufacture of products, services and solutions for In Vitro Diagnostics, headquartered in the United States with global manufacturing and sales reach. PerkinElmer's product range includes the newly launched COVID-19 RT-PCR Test in its In Vitro Diagnostics segment, which is approved by FDA and now available in 30 countries worldwide. The report, COVID-19 Impact on PerkinElmer Inc.'s Revenue and Operations (Medical Devices) presents a deep dive analysis into how PerkinElmer Inc. is placed to respond to the COVID-19 crisis, by examining its sector performance and competitiveness.
Scope
The report provides a comprehensive analysis of the impact of COVID-19 on PerkinElmer Inc. –
– It provides insights on PerkinElmer Inc.'s exposure to the regions and businesses impacted by the COVID-19 outbreak.
– It offers an overview of the company’s revenue impact by region and market for 2020 due to the COVID-19 outbreak.
Key Highlights
While PerkinElmer was impacted early on in APAC due to the COVID-19 crisis, the company’s global performance has been positive in all regions. The geographic diversification of PerkinElmer's business has been beneficial for generating revenue. With improved conditions in APAC, PerkinElmer has recuperated revenue from resumed sales in this region.
Reasons to Buy
An overview of how PerkinElmer Inc. will be affected by the COVID-19 pandemic.
Table of Contents
Frequently asked questions
Get in touch to find out about multi-purchase discounts
reportstore@globaldata.com
Tel +44 20 7947 2745
Every customer’s requirement is unique. With over 220,000 construction projects tracked, we can create a tailored dataset for you based on the types of projects you are looking for. Please get in touch with your specific requirements and we can send you a quote.